PHENYLEPHRINE HCL, WITCH HAZEL

PHENYLEPHRINE HCL, WITCH HAZEL was reported 35 times

PHENYLEPHRINE HCL, WITCH HAZEL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER THERAPY 2 0.0101
1 RUBELLA 1 0.0088
2 ANALGESIC THERAPY 2 0.0062
3 DRUG THERAPY 2 0.0059
4 APPENDICOLITH 2 0.0052
5 IRREGULAR SLEEP WAKE RHYTHM DISORDER 1 0.0050
6 PROSTATIC PAIN 1 0.0025
7 ANAL INFLAMMATION 1 0.0016
8 HYPERPHOSPHATAEMIA 2 0.0009
9 CATHETER SITE DISCHARGE 1 0.0009
10 INFUSION SITE WARMTH 1 0.0008
11 BLOOD PHOSPHORUS INCREASED 2 0.0007
12 ANORECTAL DISCOMFORT 3 0.0006
13 ANAL PRURITUS 1 0.0005
14 IRON DEFICIENCY 2 0.0004
15 URINE FLOW DECREASED 1 0.0004
16 ANIMAL BITE 1 0.0004
17 ANAL HAEMORRHAGE 1 0.0004
18 BLOOD URIC ACID INCREASED 2 0.0003
19 BLADDER PAIN 1 0.0003
20 INJECTION SITE INFECTION 1 0.0003
21 HYPOPHOSPHATAEMIA 2 0.0003
22 CATHETER SITE INFECTION 1 0.0003
23 MYASTHENIA GRAVIS 2 0.0002
24 ONYCHOMADESIS 1 0.0002
25 ONYCHOMYCOSIS 1 0.0002
26 RHEUMATIC FEVER 1 0.0002
27 APPENDICITIS 2 0.0002
28 COELIAC DISEASE 2 0.0002
29 PRODUCT COLOUR ISSUE 1 0.0002
30 PRODUCT SIZE ISSUE 1 0.0002
31 VENTRICULAR FIBRILLATION 2 0.0002
32 PRODUCT LABEL CONFUSION 1 0.0002
33 INFUSION SITE SWELLING 1 0.0002
34 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
35 PROCTALGIA 1 0.0002
36 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
37 CARDIOGENIC SHOCK 2 0.0001
38 PRODUCT USE COMPLAINT 2 0.0001
39 LIVE BIRTH 1 0.0001
40 INFUSION SITE ERYTHEMA 1 0.0001
41 NAIL DISORDER 1 0.0001
42 GRIP STRENGTH DECREASED 1 0.0001
43 BACTERIAL INFECTION 2 0.0001
44 HAEMORRHOIDS 2 0.0001
45 FOLLICULITIS 1 0.0001
46 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
47 RECTAL HAEMORRHAGE 4 0.0001
48 BURSITIS 1 0.0001
49 NEURALGIA 2 0.0001
50 PEMPHIGUS 1 0.0001
51 INJECTION SITE IRRITATION 1 0.0001
52 INFUSION SITE PAIN 1 0.0001
53 HAND DEFORMITY 1 0.0001
54 TOOTH INFECTION 1 0.0001
55 ADVERSE REACTION 1 0.0001
56 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
57 ASCITES 2 0.0001
58 BLOOD CHOLESTEROL INCREASED 3 0.0001
59 PERICARDITIS 1 0.0001
60 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
61 SYNOVITIS 1 0.0001
62 PRODUCT PHYSICAL ISSUE 1 0.0000
63 HAEMORRHAGE 5 0.0000
64 IRRITABLE BOWEL SYNDROME 1 0.0000
65 INTENTIONAL PRODUCT MISUSE 4 0.0000
66 GLOSSODYNIA 1 0.0000
67 ORAL PAIN 1 0.0000
68 BURNING SENSATION 3 0.0000
69 DRUG INTOLERANCE 4 0.0000
70 INFLAMMATION 2 0.0000
71 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
72 DRY MOUTH 3 0.0000
73 WOUND 1 0.0000
74 HYPONATRAEMIA 2 0.0000
75 LACRIMATION INCREASED 1 0.0000
76 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
77 SWELLING 3 0.0000
78 DRUG-INDUCED LIVER INJURY 1 0.0000
79 EXPIRED PRODUCT ADMINISTERED 1 0.0000
80 FUNGAL INFECTION 1 0.0000
81 TYPE 2 DIABETES MELLITUS 1 0.0000
82 ABDOMINAL DISTENSION 3 0.0000
83 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
84 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
85 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
86 CRYING 1 0.0000
87 C-REACTIVE PROTEIN INCREASED 1 0.0000
88 INJECTION SITE MASS 1 0.0000
89 DIABETES MELLITUS 2 0.0000
90 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
91 ABNORMAL BEHAVIOUR 1 0.0000
92 THROMBOSIS 2 0.0000
93 PSORIATIC ARTHROPATHY 1 0.0000
94 BALANCE DISORDER 2 0.0000
95 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
96 SKIN IRRITATION 1 0.0000
97 PULMONARY EMBOLISM 2 0.0000
98 DYSPEPSIA 2 0.0000
99 CELLULITIS 1 0.0000
100 ARTHROPATHY 1 0.0000
101 SEPSIS 2 0.0000
102 BLISTER 1 0.0000
103 EYE IRRITATION 1 0.0000
104 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
105 ILL-DEFINED DISORDER 1 0.0000
106 VERTIGO 1 0.0000
107 DISCOMFORT 1 0.0000
108 FEELING HOT 1 0.0000
109 EXPOSURE DURING PREGNANCY 1 0.0000
110 INFUSION RELATED REACTION 1 0.0000
111 NEOPLASM MALIGNANT 1 0.0000
112 SOMNOLENCE 3 0.0000
113 HEPATIC ENZYME INCREASED 1 0.0000
114 INJECTION SITE REACTION 1 0.0000
115 SLEEP DISORDER 1 0.0000
116 MOBILITY DECREASED 1 0.0000
117 CONSTIPATION 3 0.0000
118 CONDITION AGGRAVATED 4 0.0000
119 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
120 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
121 TREATMENT FAILURE 1 0.0000
122 URTICARIA 2 0.0000
123 ABDOMINAL DISCOMFORT 2 0.0000
124 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
125 MUSCULOSKELETAL STIFFNESS 1 0.0000
126 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
127 GASTROINTESTINAL DISORDER 1 0.0000
128 HYPERSENSITIVITY 2 0.0000
129 ANAEMIA 2 0.0000
130 SYNCOPE 1 0.0000
131 CHEST DISCOMFORT 1 0.0000
132 MALAISE 4 0.0000
133 RHEUMATOID ARTHRITIS 1 0.0000
134 ABDOMINAL PAIN 2 0.0000
135 PALPITATIONS 1 0.0000
136 JOINT SWELLING 1 0.0000
137 RASH 3 0.0000
138 HYPOAESTHESIA 1 0.0000
139 PARAESTHESIA 1 0.0000
140 CONFUSIONAL STATE 1 0.0000
141 TREMOR 1 0.0000
142 DIZZINESS 3 0.0000
143 CEREBROVASCULAR ACCIDENT 1 0.0000
144 URINARY TRACT INFECTION 1 0.0000
145 PRODUCT USE ISSUE 1 0.0000
146 DRUG INEFFECTIVE 7 0.0000
147 DYSPNOEA 3 0.0000
148 PRURITUS 2 0.0000
149 ALOPECIA 1 0.0000
150 ERYTHEMA 1 0.0000
151 HYPERTENSION 1 0.0000
152 OFF LABEL USE 4 0.0000
153 DECREASED APPETITE 1 0.0000
154 BACK PAIN 1 0.0000
155 VOMITING 2 0.0000
156 NAUSEA 3 0.0000
157 INSOMNIA 1 0.0000
158 COUGH 1 0.0000
159 ANXIETY 1 0.0000
160 PRODUCT DOSE OMISSION ISSUE 1 0.0000
161 INJECTION SITE PAIN 1 0.0000
162 PAIN 2 0.0000
163 HEADACHE 2 0.0000
164 DIARRHOEA 2 0.0000
165 ARTHRALGIA 1 0.0000
166 DEATH 2 0.0000
167 FATIGUE 1 0.0000